{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T17:45:40Z","timestamp":1792950340912,"version":"4.5.0"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2024,12,24]]},"abstract":"\n Importance<\/jats:title>\n Inferior vena cava filters (IVCFs) are commonly used to prevent pulmonary embolism in selected clinical scenarios, despite limited evidence to support their use. Current recommendations from professional societies and the US Food and Drug Administration endorse timely IVCF retrieval when clinically feasible. Current IVCF treatment patterns and outcomes remain poorly described.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To evaluate temporal trends and practice patterns in IVCF insertion and retrieval among older US patients and report the incidence of periprocedural and long-term safety events of indwelling and retrieved IVCFs.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n Prespecified, retrospective, observational cohort of Medicare Fee-for-Service (FFS) beneficiaries, leveraging 100% of samples of inpatient and outpatient claims data from January 1, 2013, to December 31, 2021.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n First-time IVCF insertion while insured by Medicare FFS.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary safety outcome was the composite of all-cause death, filter-related complications (eg, fracture, embolization), operating room visits following filter-related procedures, or new diagnosis of deep vein thrombosis (DVT). Events were considered periprocedural if they occurred within 30 days of IVCF insertion or retrieval and long-term if they occurred more than 30 days after.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 270\u202f866 patients with IVCFs placed during the study period (mean age, 75.1 years; 52.8% female), 64.9% were inserted for first-time venous thromboembolism (VTE), 26.3% for recurrent VTE, and 8.8% for VTE prophylaxis. Of these patients, 63.3% had major bleeds or trauma within 30 days of IVCF insertion. The volume of insertions decreased from 44\u202f680 per year in 2013 to 19\u202f501 per year in 2021. The cumulative incidence of retrieval was 15.3% at a median of 1.2 years and 16.8% at maximum follow-up of 9.0 years. Older age, more comorbidities, and Black race were associated with a decreased likelihood of retrieval, whereas placement at a large teaching hospital was associated with an increased likelihood of retrieval. The incidence of caval thrombosis and DVT among patients with nonretrieved IVCFs was 2.2% (95% CI, 2.1%-2.3%) and 9.2% (95% CI, 9.0%-9.3%), respectively. The majority (93.5%) of retrieval attempts were successful, with low incidence of 30-day complications (mortality, 0.7% [95% CI, 0.6%-0.8%]; filter-related complications, 1.4% [95% CI, 1.2%-1.5%]).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this large, US real-world analysis, IVCF insertion declined, yet retrievals remained low. Strategies to increase timely retrieval are needed, as nonretrieved IVCFs may have long-term complications.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jama.2024.19553","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T11:00:35Z","timestamp":1730890835000},"page":"2091","source":"Crossref","is-referenced-by-count":41,"title":["Postmarketing Surveillance of Inferior Vena Cava Filters Among US Medicare Beneficiaries"],"prefix":"10.1001","volume":"332","author":[{"given":"Enrico G.","family":"Ferro","sequence":"first","affiliation":[{"name":"Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie B.","family":"Mackel","sequence":"additional","affiliation":[{"name":"Office of Cardiovascular Devices, Center for Devices and Radiological Health (CDRH), US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee D.","family":"Kramer","sequence":"additional","affiliation":[{"name":"Office of Clinical Evidence and Analysis (OCEA), Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Torguson","sequence":"additional","affiliation":[{"name":"Office of Clinical Evidence and Analysis (OCEA), Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni M.","family":"Whatley","sequence":"additional","affiliation":[{"name":"Office of Cardiovascular Devices, Center for Devices and Radiological Health (CDRH), US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"O\u2019Connell","sequence":"additional","affiliation":[{"name":"Office of Cardiovascular Devices, Center for Devices and Radiological Health (CDRH), US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Pullin","sequence":"additional","affiliation":[{"name":"Office of Cardiovascular Devices, Center for Devices and Radiological Health (CDRH), US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan W.","family":"Watson","sequence":"additional","affiliation":[{"name":"Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siling","family":"Li","sequence":"additional","affiliation":[{"name":"Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[{"name":"Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Krawisz","sequence":"additional","affiliation":[{"name":"Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett J.","family":"Carroll","sequence":"additional","affiliation":[{"name":"Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc L.","family":"Schermerhorn","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Weinstein","sequence":"additional","affiliation":[{"name":"Division of Interventional Radiology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Farb","sequence":"additional","affiliation":[{"name":"Office of Cardiovascular Devices, Center for Devices and Radiological Health (CDRH), US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Zuckerman","sequence":"additional","affiliation":[{"name":"Office of Cardiovascular Devices, Center for Devices and Radiological Health (CDRH), US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Yeh","sequence":"additional","affiliation":[{"name":"Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Secemsky","sequence":"additional","affiliation":[{"name":"Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"13","key":"joi240110r1","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.jacc.2017.07.775","article-title":"Inferior vena cava filters to prevent pulmonary embolism: systematic review and meta-analysis.","volume":"70","author":"Bikdeli","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"joi240110r2","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jacc.2015.12.028","article-title":"Vena caval filter utilization and outcomes in pulmonary embolism: Medicare hospitalizations from 1999 to 2010.","volume":"67","author":"Bikdeli","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"joi240110r3","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.jacr.2018.01.037","article-title":"Rising retrieval rates of inferior vena cava filters in the United States: insights from the 2012 to 2016 summary Medicare claims data.","volume":"15","author":"Ahmed","year":"2018","journal-title":"J Am Coll Radiol"},{"issue":"19","key":"joi240110r4","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"issue":"10","key":"joi240110r5","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.jvir.2020.06.014","article-title":"Society of Interventional Radiology clinical practice guideline for inferior vena cava filters in the treatment of patients with venous thromboembolic disease: developed in collaboration with the American College of Cardiology, American College of Chest Physicians, American College of Surgeons Committee on Trauma, American Heart Association, Society for Vascular Surgery, and Society for Vascular Medicine.","volume":"31","author":"Kaufman","year":"2020","journal-title":"J Vasc Interv Radiol"},{"issue":"7","key":"joi240110r6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1056\/NEJM199802123380701","article-title":"A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis.","volume":"338","author":"Decousus","year":"1998","journal-title":"N Engl J Med"},{"issue":"3","key":"joi240110r7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1161\/CIRCULATIONAHA.104.512834","article-title":"Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d\u2019Embolie Pulmonaire par Interruption Cave) randomized study.","volume":"112","author":"PREPIC Study Group","year":"2005","journal-title":"Circulation"},{"issue":"16","key":"joi240110r8","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1001\/jama.2015.3780","article-title":"Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial.","volume":"313","author":"Mismetti","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"joi240110r9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1056\/NEJMoa1806515","article-title":"A multicenter trial of vena cava filters in severely injured patients.","volume":"381","author":"Ho","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"joi240110r10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1161\/CIRCULATIONAHA.105.592592","article-title":"Massive pulmonary embolism.","volume":"113","author":"Kucher","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"joi240110r11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.0452","article-title":"Association of inferior vena cava filter placement for venous thromboembolic disease and a contraindication to anticoagulation with 30-day mortality.","volume":"1","author":"Turner","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"2","key":"joi240110r12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1001\/jamainternmed.2018.5287","article-title":"Association of inferior vena cava filter use with mortality rates in older adults with acute pulmonary embolism.","volume":"179","author":"Bikdeli","year":"2019","journal-title":"JAMA Intern Med"},{"key":"joi240110r13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.critrevonc.2018.07.005","article-title":"Role of vena cava filters for the management of cancer-related venous thromboembolism: systematic review and meta-analysis.","volume":"130","author":"Rojas-Hernandez","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"issue":"20","key":"joi240110r14","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1001\/archinternmed.2010.316","article-title":"Prevalence of fracture and fragment embolization of Bard retrievable vena cava filters and clinical implications including cardiac perforation and tamponade.","volume":"170","author":"Nicholson","year":"2010","journal-title":"Arch Intern Med"},{"issue":"12","key":"joi240110r18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.48159","article-title":"Safety and success rates of excimer laser sheath-assisted retrieval of embedded inferior vena cava filters.","volume":"5","author":"Desai","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"joi240110r19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jvir.2022.12.009","article-title":"Predicting the safety and effectiveness of inferior vena cava filters (PRESERVE): outcomes at 12 months.","volume":"34","author":"Johnson","year":"2023","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"joi240110r23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2023.08.022","article-title":"Racial and ethnic disparities in inferior vena cava filter placement for deep vein thrombosis in the United States.","volume":"12","author":"Juarez","year":"2024","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"6","key":"joi240110r24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jacr.2022.03.011","article-title":"Population-based disparities in inferior vena cava filter procedures among Medicare enrollees with acute venous thromboembolism.","volume":"19","author":"Williams","year":"2022","journal-title":"J Am Coll Radiol"},{"key":"joi240110r25","doi-asserted-by":"publisher","first-page":"l4563","DOI":"10.1136\/bmj.l4563","article-title":"Hospital revisits within 30 days after discharge for medical conditions targeted by the Hospital Readmissions Reduction Program in the United States: national retrospective analysis.","volume":"366","author":"Wadhera","year":"2019","journal-title":"BMJ"},{"issue":"446","key":"joi240110r26","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"27","key":"joi240110r27","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data.","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"issue":"21","key":"joi240110r28","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1002\/sim.4780132105","article-title":"Cox regression analysis of multivariate failure time data: the marginal approach.","volume":"13","author":"Lin","year":"1994","journal-title":"Stat Med"},{"issue":"9","key":"joi240110r29","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.jacr.2017.04.022","article-title":"Decreasing utilization of inferior vena cava filters in post-FDA warning era: insights from 2005 to 2014 nationwide inpatient sample.","volume":"14","author":"Wadhwa","year":"2017","journal-title":"J Am Coll Radiol"},{"issue":"9","key":"joi240110r30","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1001\/jamainternmed.2017.2719","article-title":"Association between contemporary trends in inferior vena cava filter placement and the 2010 US Food and Drug Administration advisory.","volume":"177","author":"Reddy","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"1","key":"joi240110r31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1358863X16676658","article-title":"A multidisciplinary quality improvement program increases the inferior vena cava filter retrieval rate.","volume":"22","author":"Winters","year":"2017","journal-title":"Vasc Med"},{"issue":"12","key":"joi240110r32","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.jvir.2010.09.003","article-title":"Improving inferior vena cava filter retrieval rates: impact of a dedicated inferior vena cava filter clinic.","volume":"21","author":"Minocha","year":"2010","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"joi240110r34","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2021.0527","article-title":"Time and financial costs for physician practices to participate in the Medicare Merit-based Incentive Payment System: a qualitative study.","volume":"2","author":"Khullar","year":"2021","journal-title":"JAMA Health Forum"},{"issue":"2","key":"joi240110r35","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.amjcard.2018.09.040","article-title":"Usefulness of a computerized reminder system to improve inferior vena cava filter retrieval and complications.","volume":"123","author":"Mikhael","year":"2019","journal-title":"Am J Cardiol"},{"issue":"6","key":"joi240110r36","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s10278-023-00882-1","article-title":"Detecting and characterizing inferior vena cava filters on abdominal computed tomography with data-driven computational frameworks.","volume":"36","author":"Candemir","year":"2023","journal-title":"J Digit Imaging"},{"issue":"1","key":"joi240110r37","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1182\/hematology.2020000149","article-title":"Inferior vena cava filters: a framework for evidence-based use.","volume":"2020","author":"Kelkar","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"joi240110r40","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2214\/AJR.17.19148","article-title":"Reporting of inferior vena cava filter complications on CT: impact of standardized macros.","volume":"211","author":"Shin","year":"2018","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"joi240110r41","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1055\/s-0043-1777991","article-title":"Developmental or procedural vena cava interruption and venous thromboembolism: a review.","volume":"50","author":"Bikdeli","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"joi240110r15","unstructured":"US Food and Drug Administration. Removing retrievable inferior vena cava filters: initial communication. Published online August 9, 2010. Accessed June 7, 2024. https:\/\/wayback.archive-it.org\/7993\/20161022180008\/http:\/www.fda.gov\/MedicalDevices\/Safety\/AlertsandNotices\/ucm221676.htm"},{"key":"joi240110r16","unstructured":"US Food and Drug Administration. Removing retrievable inferior vena cava filters: FDA safety communication. Published online May 6, 2014. Accessed June 7, 2024. http:\/\/wayback.archive-it.org\/7993\/20170722215731\/https:\/\/www.fda.gov\/MedicalDevices\/Safety\/AlertsandNotices\/ucm396377.htm"},{"key":"joi240110r17","unstructured":"US Food and Drug Administration. 522 Postmarket Surveillance Studies Program. Accessed June 7, 2024. https:\/\/www.fda.gov\/medical-devices\/postmarket-requirements-devices\/522-postmarket-surveillance-studies-program"},{"key":"joi240110r20","unstructured":"Centers for Medicare & Medicaid Services. Chronic Conditions Data Warehouse. Accessed June 7, 2024. https:\/\/www2.ccwdata.org\/web\/guest\/condition-categories-chronic"},{"key":"joi240110r21","unstructured":"American Hospital Association. Annual Survey Database. Accessed June 7, 2024. https:\/\/www.ahadata.com\/aha-annual-survey-database"},{"key":"joi240110r22","unstructured":"Economic Innovation Group. Distressed communities\u2014methodology. Accessed June 7, 2024. https:\/\/eig.org\/distressed-communities\/2022-dci-methodology\/"},{"key":"joi240110r33","unstructured":"American Medical Association. Quality ID #421: appropriate assessment of retrievable inferior vena cava (IVC) filters for removal. Published online December 2023. Accessed June 7, 2024. https:\/\/www.acr.org\/-\/media\/ACR\/NOINDEX\/Measures\/2024_Measure_421_MIPSCQM.pdf"},{"key":"joi240110r38","unstructured":"Kaiser Family Foundation. Distribution of Medicare beneficiaries by race\/ethnicity. Accessed June 7, 2024. https:\/\/www.kff.org\/medicare\/state-indicator\/medicare-beneficiaries-by-raceethnicity\/?currentTimeframe=7&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D"},{"key":"joi240110r39","unstructured":"Kaiser Family Foundation. Enrollment and spending patterns among Medicare-Medicaid enrollees (dual eligibles). Published online January 31, 2023. Accessed June 7, 2024. https:\/\/www.kff.org\/medicaid\/issue-brief\/enrollment-and-spending-patterns-among-medicare-medicaid-enrollees-dual-eligibles\/"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2825899\/jama_ferro_2024_oi_240110_1734384551.04286.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T11:01:00Z","timestamp":1735038060000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2825899"}},"subtitle":["The SAFE-IVC Study"],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":41,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2024,12,24]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2024.19553","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,24]]}}}